In this episode, Peter Holme, the CEO of Cambiotics, discusses his new startup, a spinoff from the University of Cambridge aimed at detoxifying the human body from harmful PFAS chemicals using precision probiotics. Peter shares his extensive background as a scientist and entrepreneur, including his journey with Aquapoint and his involvement in innovation in Denmark. He explains the science behind Cambiotics, the current stage of the company, and the challenges they face in transitioning from lab and animal studies to human clinical trials. Peter highlights their plan to introduce the product to the U.S. market by partnering with the American Firefighter Associations, who are at high risk of PFAS exposure. He also discusses the company's participation in TechBBQ and emphasizes the critical need for global awareness about PFAS pollution.

Timestamps:

00:00 Introduction to Peter Holme and Cambiotics

01:58 Overview of Cambiotics

02:34 Technology Behind Cambiotics

03:21 Current Stage and Future Plans

04:02 Challenges and Clinical Trials

06:56 Participation in Tech Barbecue

08:07 Raising Awareness About PFAS

09:58 Conclusion and Final Thoughts

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach